Breaking News Instant updates and real-time market news.

AVXS

AveXis

$56.94

0.43 (0.76%)

08:04
11/30/16
11/30
08:04
11/30/16
08:04

AveXis price target raised to $91 from $71 at Goldman

Goldman analyst Salveen Richter raised AveXis' price target to $91 from $71 to reflect a shorter time to peak penetration of AVXS-101 to 4 years from 5 years prior. Richter also added Japan and ROW sales to AVXS-101 resulting in peak sales estimate of $925M from $805M in 2026. The analyst maintains a 2020 US launch but awaits visibility on the accelerated approval pathway on the current Phase 1 data expected in 1H 2017 and reiterates his Buy rating on shares.

  • 14

    Dec

AVXS AveXis
$56.94

0.43 (0.76%)

11/02/16
JEFF
11/02/16
NO CHANGE
Target $71
JEFF
Buy
AveXis price target raised to $71 from $58 at Jefferies
Jefferies analyst Biren Amin raised his price target for AveXis to $71 saying the AVXS-101 trial dialogue with the FDA was better than expected. The FDA has signed off on a pivotal single-arm trial design versus natural history while enrollment will be about 20 patients, much smaller than expectations, Amin tells investors in a research note. All of the points made by the FDA are "very positive" for AveXis, Amin contends. He keeps a Buy rating on the shares. The stock is up 14%, or $6.86, to $54.87 in pre-market trading.
11/02/16
BMOC
11/02/16
NO CHANGE
BMOC
AveXis price target raised to $80 from $52 at BMO Capital
BMO Capital analyst M. Ian Somaiya pulled forward his time frame for FDA approval of AveXis' AVXS-101m drug by 12 months. The analyst now sees a roughly 70% chance of the drug launching by late 2017 to early 2018 if the FDA accepts the company's Phase I filing. The analyst says that the FDa's willingness to accept the company's 20 patient Phase II trial shows the strength of the Phase I data. He keeps an Outperform rating o nthe shares.
11/07/16
PIPR
11/07/16
NO CHANGE
PIPR
Biogen, Ionis get jump start on AveXis, says Piper Jaffray
Piper Jaffray analyst Joshua Schimmer says that following his upgrade this morning, Biogen (BIIB) and its partner Ionis Pharmaceuticals (IONS) announced that a Phase III study of nusinersen met its primary endpoint. The data look "very good," Schimmer tells investors in a research note. This gives Biogen and Ionis a jump start on rival gene therapy player AveXis for the Type II/III setting, Schimmer tells investors in a research note. If not for competition from AveXis, nusinersen would become a $5B-plus mega-blockbuster by addressing one of the highest unmet needs in pediatric diseases that exists today, the analyst contends. Schimmer believes, however, that AveXis is moving quickly to compete in the market. The analyst still hopes Biogen "will find a way to partner" with AveXis. He still thinks nusinersen, which is now called SPINRAZA, can achieve $1B-$2B-plus in peak annual revenue. Following this morning's upgrade, Schimmer has an Overweight rating on Biogen with a $335 price target.
11/14/16
STFL
11/14/16
INITIATION
Target $65
STFL
Hold
AveXis initiated with a Hold at Stifel
Stifel analyst Katherine Breedis initiated AveXis with a Hold and a $65 price target.

TODAY'S FREE FLY STORIES

BWLD

Buffalo Wild Wings

$170.85

2.75 (1.64%)

09:08
12/06/16
12/06
09:08
12/06/16
09:08
Hot Stocks
Marcato launches dedicated website to express views on Buffalo Wild Wings »

Marcato Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDC

Belden

$74.99

0.9 (1.21%)

, DGII

Digi International

$13.65

0.1 (0.74%)

09:07
12/06/16
12/06
09:07
12/06/16
09:07
Hot Stocks
Breaking Hot Stocks news story on Belden, Digi International »

Belden…

BDC

Belden

$74.99

0.9 (1.21%)

DGII

Digi International

$13.65

0.1 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBAN

Huntington Bancshares

$13.03

0.09 (0.70%)

09:06
12/06/16
12/06
09:06
12/06/16
09:06
Initiation
Huntington Bancshares initiated  »

Huntington Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

BDC

Belden

$74.99

0.9 (1.21%)

, DGII

Digi International

$13.65

0.1 (0.74%)

09:06
12/06/16
12/06
09:06
12/06/16
09:06
Hot Stocks
Breaking Hot Stocks news story on Belden, Digi International »

Belden: Offer for Digi…

BDC

Belden

$74.99

0.9 (1.21%)

DGII

Digi International

$13.65

0.1 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDC

Belden

$74.99

0.9 (1.21%)

, DGII

Digi International

$13.65

0.1 (0.74%)

09:05
12/06/16
12/06
09:05
12/06/16
09:05
Hot Stocks
Belden: Digi management, board 'unwilling' to engage in discussions with Belden »

Notes…

BDC

Belden

$74.99

0.9 (1.21%)

DGII

Digi International

$13.65

0.1 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCE.A

Forest City

$18.75

0.45 (2.46%)

, FCE.B

Forest City

$19.25

0.56 (3.00%)

09:05
12/06/16
12/06
09:05
12/06/16
09:05
Hot Stocks
Forest City recommends shareholders to eliminate dual-class share structure »

Forest City Realty Trust…

FCE.A

Forest City

$18.75

0.45 (2.46%)

FCE.B

Forest City

$19.25

0.56 (3.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDC

Belden

$74.99

0.9 (1.21%)

, DGII

Digi International

$13.65

0.1 (0.74%)

09:05
12/06/16
12/06
09:05
12/06/16
09:05
Hot Stocks
Belden reiterates $13.82 per share offer to Digi International board »

Belden (BDC) announced…

BDC

Belden

$74.99

0.9 (1.21%)

DGII

Digi International

$13.65

0.1 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BW

Babcock & Wilcox

$15.99

0.46 (2.96%)

09:04
12/06/16
12/06
09:04
12/06/16
09:04
Hot Stocks
B&W names D. Paul Scavuzzo Chief Commercial Officer »

Babcock & Wilcox…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

XPLR

Xplore Technologies

$2.31

-0.0124 (-0.53%)

09:04
12/06/16
12/06
09:04
12/06/16
09:04
Hot Stocks
Xplore Technologies receives second rugged tablet follow-on order »

Xplore Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

BA

Boeing

$152.16

-0.09 (-0.06%)

09:03
12/06/16
12/06
09:03
12/06/16
09:03
Periodicals
Trump wants to cancel Boeing Air Force One order »

President-elect Donald…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLJ

RLJ Lodging Trust

$23.38

0.86 (3.82%)

09:03
12/06/16
12/06
09:03
12/06/16
09:03
Hot Stocks
RLJ Lodging Trust announces sale of two hotels in NYC for $286M »

RLJ Lodging Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEIC

SEI Investments

$48.16

1.2 (2.56%)

09:03
12/06/16
12/06
09:03
12/06/16
09:03
Hot Stocks
SEI Investments signs three-year contract extension with Veritas Investment »

SEI UK Private Banking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUE

Nucor

$65.10

2.07 (3.28%)

09:02
12/06/16
12/06
09:02
12/06/16
09:02
Hot Stocks
Nucor to acquire Southland Tube for $130M »

Nucor announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSTX

Mast Therapeutics

$0.08

0.0009 (1.08%)

09:01
12/06/16
12/06
09:01
12/06/16
09:01
Hot Stocks
Mast Therapeutics enrolls first patient in Phase 2 study of AIR001 »

Mast Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNSL

Consolidated Communications

$27.21

-1.17 (-4.12%)

09:01
12/06/16
12/06
09:01
12/06/16
09:01
Upgrade
Consolidated Communications rating change  »

Consolidated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

NLSN

Nielsen

$42.41

0.34 (0.81%)

09:01
12/06/16
12/06
09:01
12/06/16
09:01
Conference/Events
Nielsen to host 2016 analyst day »

2016 Analyst Day to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 08

    Dec

CMG

Chipotle

$396.27

-3.76 (-0.94%)

09:00
12/06/16
12/06
09:00
12/06/16
09:00
Hot Stocks
Chipotle says sales haven't recovered as much as previously expected »

Says "took eye off…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

RGSE

Real Goods Solar

$0.51

0.0596 (13.23%)

09:00
12/06/16
12/06
09:00
12/06/16
09:00
Syndicate
Breaking Syndicate news story on Real Goods Solar »

Real Goods Solar files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:00
12/06/16
12/06
09:00
12/06/16
09:00
General news
U.S. trade deficit widened 17.8% to -$42.6 B in October »

U.S. trade deficit…

REI

Ring Energy

$12.15

-0.81 (-6.25%)

08:59
12/06/16
12/06
08:59
12/06/16
08:59
Syndicate
Ring Energy 6.5M share Spot Secondary priced at $11.50 »

SunTrust and Seaport…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

NSTG

NanoString

$21.99

-0.15 (-0.68%)

08:59
12/06/16
12/06
08:59
12/06/16
08:59
Recommendations
NanoString analyst commentary  »

NanoString a top growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

T

AT&T

$38.63

0.02 (0.05%)

, TWX

Time Warner

$93.34

-0.46 (-0.49%)

08:57
12/06/16
12/06
08:57
12/06/16
08:57
Hot Stocks
AT&T CEO says Time Warner review should be 'straightforward' »

Says Time Warner (TWX)…

T

AT&T

$38.63

0.02 (0.05%)

TWX

Time Warner

$93.34

-0.46 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 07

    Dec

08:56
12/06/16
12/06
08:56
12/06/16
08:56
General news
Redbook Store Sales data reported »

Week of 12/3 Redbook…

TDOC

Teladoc

$18.45

0.5 (2.79%)

08:55
12/06/16
12/06
08:55
12/06/16
08:55
Hot Stocks
Teladoc says reached 100,000 telehealth visits during November »

Teladoc announced that a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$21.84

0.61 (2.87%)

, AAPL

Apple

$109.11

-0.79 (-0.72%)

08:55
12/06/16
12/06
08:55
12/06/16
08:55
Options
Notable open interest changes for December 6th »

Monday's total…

BAC

Bank of America

$21.84

0.61 (2.87%)

AAPL

Apple

$109.11

-0.79 (-0.72%)

RAD

Rite Aid

$8.06

0.05 (0.62%)

F

Ford

$12.44

0.2 (1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 05

    Jan

  • 10

    Jan

  • 13

    Jan

  • 13

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.